Table 2 Characters of the 3 patients who developed relapse
From: Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan
No. | Age (years) | T stage | Ochiectomy approach | Adjuvant radiotherapy field (dose) | Pathological risk features | Preoperative tumor markers | Postoperative tumor markers | Abnormality if tumor marker levels prior to relapse | Method of detection of relapse | Site of relapse | Time from radiotherapy to relapse (months) | Treatment | Outcome (time at follow-up from relapse) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 40 | T1 | Inguinal | Para-aortic (20 Gy/10Fx) | 4.6 cm tumor | Normal | Normal | No | CT scan | Left hilum | 25 | Chemotherapy (BEPx4 cycles) | ANED (32 months) |
2 | 34 | T2 | Inguinal | Para-aortic (20/10Fx) | 6 cm tumor | Not available | Normal | No | CT scan | Retro- peritoneal LN | 8 | Chemotherapy (BEPx4 cycles, TIPx4 cycles, VIPx4 cycles, GOPx8 cycles) | DDD (25 months) |
3 | 38 | T2 | Inguinal | Para-aortic (20/10Fx) | 8 cm tumor | Normal | Normal | No | Clinical examination | Supra- clavicular LN | 14 | Chemotherapy (BEPx4 cycles) | AWD (12 months) |